Celgene Corporation to Webcast at Upcoming Investor Conferences

On February 1, 2018 Celgene Corporation (NASDAQ: CELG) reported that it plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company (Press release, Celgene, FEB 1, 2018, View Source [SID1234523678]). The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Thursday, February 15, 2018, Celgene will present at the Leerink Partners Global Healthcare Conference in New York City at 1:30 pm ET

Wednesday, February 21, 2018, Celgene will present at the RBC Capital Markets 2018 Global Healthcare Conference in New York City at 11:30 am ET

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!